Vaccine Manufacture and Supply – News and Features

Total funding for these contracts reach approximately $70 million over five years.

A new antigens formulation against pandemic flu (A H1N1 virus) proved six times more effective than other vaccines.

Emmanuel will oversee all worldwide commercial activities of Company's rapidly growing BioProcess business.

Performing microcarrier culture using an automated microscale bioreactor system offers a method of improved process development for production of vaccine using attachment dependent cells.

Company now has over 1,700 employees spread across seven production facilities.

Study continues to report encouraging response rates, safety and proof of mechanism.

Adaptimmune announces that study continues to report encouraging response rates, safety and proof of mechanism.

Funding will be provided by Leidos through its Malaria Vaccine Production and Support Services Contract with NIAID, part of the National Institutes of Health.

Company offers licenses and contract research services to human and animal vaccine companies.

The joint initiative will endeavour to make vaccines more resistant to heat, thus reducing the need for refrigeration.